COVID-19 Vaccine

Outbreaks of infectious diseases have been recorded throughout history. Currently, SARS-CoV-2, a contagious virus that causes the disease called COVID-19, is impacting individuals worldwide. Many countries have set their sight on an effective vaccination program to end their infectious disease outbreaks. The term “herd immunity” has been mentioned in association with ending the COVID-19 outbreaks.
0 Comments
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Dec. 23, 2020– Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that Health Canada has authorized its vaccine against COVID-19 for the immunization of people 18 years of age and older under an Interim Order. “I want to thank Health
0 Comments
Now that the first COVID-19 vaccines are being rolled out, Operation Warp Speed, the FDA, and the CDC have recommended that governors proceed first with vaccinating two groups: healthcare workers and residents in nursing homes. But what about after that? Planning has started in all the states and territories regarding who will get the vaccine
0 Comments
National Institutes of Health Director Dr. Francis Collins told CNBC that “it was very likely” that the U.S. government is close to a deal with Pfizer for up to an additional 100 million Covid vaccine doses.  “It is good news it sounds like it’s very likely,” said Collins. “We’ll have 400 million doses between Pfizer
0 Comments
NEW YORK and MAINZ, GERMANY, December 12, 2020 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) voted today to recommend the use of the Pfizer-BioNTech COVID-19 vaccine in people 16 years of age and older under the Emergency Use Authorization
0 Comments
Print this page PLYMOUTH MEETING, Pa., Sept. 28, 2020 /PRNewswire/ — INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, announced that the U.S. Food and Drug Administration (FDA) has notified the company it has additional questions about the company’s
0 Comments